Study Stopped
Poor recruitment
Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion
1 other identifier
interventional
20
1 country
1
Brief Summary
This study will evaluate the effect of the timing of treatment completion in two-staged selective laser trabeculoplasty therapy on intraocular pressure lowering effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2007
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 29, 2007
CompletedFirst Posted
Study publicly available on registry
October 31, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedSeptember 23, 2015
September 1, 2015
1.3 years
October 29, 2007
September 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intraocular pressure lowering
1 month following procedure
Secondary Outcomes (1)
intraocular pressure lowering
3, 6, 12 and 24 months following procedure
Study Arms (2)
SLT Early Completion (Arm 1)
EXPERIMENTALIntervention: 180 degrees of laser on Day 1, 180 degrees of laser on the other 180 degree on Day 2
SLT Late Completion (Arm 2)
ACTIVE COMPARATORIntervention: 180 degrees of laser on Day 1, 180 degrees of laser on the other 180 degrees at 1 month follow up appointment.
Interventions
180 degrees of laser on day 1 and other 180 degrees on day 2.
180 degrees of laser on day 1 and other 180 degrees at 1 month follow up point.
Eligibility Criteria
You may qualify if:
- years of age
- primary open angle glaucoma or pseudoexfoliation glaucoma
You may not qualify if:
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hotel Dieu Hospital & Queen's University
Kingston, Ontario, K7L 5G2, Canada
Related Publications (1)
Rolim-de-Moura CR, Paranhos A Jr, Loutfi M, Burton D, Wormald R, Evans JR. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3.
PMID: 35943114DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert J Campbell, MD
Queen's University, Kingston, Canada
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 29, 2007
First Posted
October 31, 2007
Study Start
September 1, 2007
Primary Completion
January 1, 2009
Study Completion
January 1, 2009
Last Updated
September 23, 2015
Record last verified: 2015-09